S(+)-2-mercapto-3-phenylpropionic acid | 72772-24-8

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 苯丙酸
• 英文名称: S(+)-2-mercapto-3-phenylpropionic acid
• 英文别名: α-mercapto-β-phenylpropionic acid；S/R-2-mercapto-3-phenylpropionic acid；2-mercapto-3-phenylpropanoic acid；3-phenyl-2-sulfanylpropanoic acid；2-mercapto-2-benzylacetic acid；2-mercapto-3-phenyl-propionic acid
• CAS: 72772-24-8；84800-12-4；84800-13-5；90536-15-5
• 化学式: C₉H₁₀O₂S
• 分子量: 182.243
• InChiKey: HGIOOMCLOWLFTJ-UHFFFAOYSA-N

物化性质

• 沸点：
  310.0±35.0 °C(Predicted)
• 密度：
  1.232±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  38.3
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  S(+)-2-mercapto-3-phenylpropionic acid 在 盐酸 、 lithium aluminium tetrahydride 作用下， 以 乙醚 、 苯 为溶剂， 生成 8-methyl-4'-benzyl-(3endoO)-spiro[8-aza-bicyclo[3.2.1]octane-3,2'-[1,3]oxathiolane]
  参考文献：
  名称：

  1-甲基-4-哌啶酮和肌钙蛋白的缩酮和半硫缩酮。

  摘要：

  DOI：

  10.1002/jps.2600500606
• 作为产物：
  描述：

  3-phenyl-2-sulfanylpropenoic acid 在 sodium amalgam 作用下， 生成 S(+)-2-mercapto-3-phenylpropionic acid
  参考文献：
  名称：

  Fischer,E.; Brieger, Chemische Berichte, 1914, vol. 47, p. 2471

  摘要：

  DOI：

文献信息

• Catalytic Enantioselective Synthesis of Tertiary Thiols From 5<i>H</i>-Thiazol-4-ones and Nitroolefins: Bifunctional Ureidopeptide-Based Brønsted Base Catalysis
  作者：Saioa Diosdado、Julen Etxabe、Joseba Izquierdo、Aitor Landa、Antonia Mielgo、Iurre Olaizola、Rosa López、Claudio Palomo

  DOI：10.1002/anie.201305644

  日期：2013.11.4

  Fully loaded: The ureidopeptide‐based bifunctional Brønsted base 1 efficiently promotes the first direct catalytic Michael reaction of α‐mercapto carboxylate surrogates with nitroolefins involving a fully substituted α‐carbon atom construction.

  满载：基于脲肽的双官能布朗斯台德碱1有效促进α-巯基羧酸盐替代物与硝基烯烃的第一个直接催化迈克尔反应，该反应涉及完全取代的α-碳原子结构。
• Colorant compounds
  申请人：Banning H. Jeffrey

  公开号：US20060020141A1

  公开（公告）日：2006-01-26

  Compounds of the formula wherein M is either (1) a metal ion having a positive charge of +y wherein y is an integer which is at least 2, said metal ion being capable of forming a compound with at least two chromogen moieties, or (2) a metal-containing moiety capable of forming a compound with at least two chromogen moieties, z is an integer representing the number of chromogen moieties associated with the metal and is at least 2, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , a, b, c, d, Y, and z are as defined herein, Q − is a COO − group or a SO 3 — group, A is an organic anion, and CA is either a hydrogen atom or a cation associated with all but one of the Q − groups.

  式中的化合物，其中M是一个带有正电荷+y的金属离子，其中y是至少为2的整数，该金属离子能够与至少两个色团基团形成化合物，或者M是一个含金属基团的基团，能够与至少两个色团基团形成化合物，z是表示与金属相关的色团基团数量的整数，至少为2，R1、R2、R3、R4、R5、R6、R7、a、b、c、d、Y和z的定义如上所述，Q-是一个COO-基团或SO3-基团，A是一个有机阴离子，CA是一个氢原子或与除一个Q-基团之外的所有Q-基团相关联的阳离子。
• Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders
  申请人：Reddy E. Premkumar

  公开号：US20080058290A1

  公开（公告）日：2008-03-06

  Substituted phenol derivatives of Formula (I) are useful as antiproliferative agents including, for example, anticancer agents, and as radioprotective and chemoprotective agents.

  公式（I）的取代酚衍生物可用作抗增殖剂，包括例如抗癌剂，以及放射防护和化学防护剂。
• COMPOSITION AND METHODS FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA
  申请人：Reddy E. Premkumar

  公开号：US20100305059A1

  公开（公告）日：2010-12-02

  Methods and compositions are provided for treating myelodysplastic syndrome and acute myeloid leukemia, wherein the composition comprises at least one compound according to Formula I: wherein R 1 is selected from the group consisting of —NH 2 , —NH—CH 2 —CO 2 H, —NH—CH(CH 3 )—CO 2 H, and —NH—C(CH 3 ) 2 —CO 2 H, or a pharmaceutically acceptable salt of such a compound; and a DNA methyltransferase inhibitor, or a pharmaceutically acceptable salt thereof.

  提供了用于治疗骨髓增生异常综合征和急性髓系白血病的方法和组合物，其中该组合物包括至少一种符合以下式I的化合物：其中R1选自—NH2、—NH—CH2—CO2H、—NH—CH(CH3)—CO2H和—NH—C(CH3)2—CO2H的群组，或者该化合物的药用可接受盐；以及DNA 甲基转移酶抑制剂，或其药用可接受盐。
• Peptidylaminodiols
  申请人：Abbott Laboratories

  公开号：US05032577A1

  公开（公告）日：1991-07-16

  A renin inhibiting compound of the formula: ##STR1## wherein A is a substituent; W is C.dbd.O or CHOH; U is CH.sub.2 or NR.sub.2, provided that when W is CHOH then U is CH.sub.2 ; R.sub.1 is loweralkyl, cycloalkylmethyl, benzyl, 4-methoxybenzyl, halobenzyl, (1-naphthyl)methyl, (2-naphthyl)methyl, (4-imidazoyl)methyl, (alpha,alpha)-dimethylbenzyl, 1-benzyloxyethyl, phenethyl, phenoxy, thiophenoxy or anilino; R.sub.2 is hydrogen or loweralkyl; R.sub.3 is loweralkenyl, [(alkoxy)alkoxy]alkyl, (thioalkoxy)alkyl, lowerakenyl, benzyl or heterocyclic ring substituted methyl; R.sub.4 is loweralkyl, cycloalkylmethyl or benzyl; R.sub.5 is vinyl, formyl, hydroxymethyl or hydrogen; R.sub.7 is hydrogen or loweralkyl; R.sub.8 and R.sub.9 are independently selected from OH and NH.sub.2 ; and R.sub.6 is hydrogen, loweralkyl, vinyl or arylalkyl; provided that when R.sub.5 and R.sub.7 are both hydrogen and R.sub.8 and R.sub.9 are OH, the carbon bearing R.sub.5 is of the "R" configuration and the carbon bearing R.sub.6 is of the "S" configuration, or pharmaceutically acceptable salts or esters thereof. Also disclosed are renin inhibiting compositions, a method of treating hypertension, methods of making the renin inhibiting compounds and intermediates useful in making the renin inhibiting compounds.

  一种肾素抑制化合物的公式为：##STR1## 其中A是取代基；W是C.dbd.O或CHOH；U是CH.sub.2或NR.sub.2，但当W为CHOH时，U为CH.sub.2；R.sub.1是较低的烷基，环烷基甲基，苄基，4-甲氧基苄基，卤苄基，(1-萘基)甲基，(2-萘基)甲基，(4-咪唑基)甲基，(α，α)-二甲基苄基，1-苄氧基乙基，苯乙基，苯氧基，硫代苯氧基或苯胺基；R.sub.2是氢或较低的烷基；R.sub.3是较低烯基，[(烷氧基)烷氧基]烷基，(硫代烷氧基)烷基，较低烯基，苄基或杂环戒指取代的甲基；R.sub.4是较低的烷基，环烷基甲基或苄基；R.sub.5是乙烯基，甲酰基，羟甲基或氢；R.sub.7是氢或较低的烷基；R.sub.8和R.sub.9分别选自OH和NH.sub.2；R.sub.6是氢，较低的烷基，乙烯基或芳基烷基；但当R.sub.5和R.sub.7都是氢且R.sub.8和R.sub.9是OH时，承载R.sub.5的碳为“R”构型，承载R.sub.6的碳为“S”构型，或其药用盐或酯。还公开了肾素抑制组合物，治疗高血压的方法，制备肾素抑制化合物的方法以及制备肾素抑制化合物中有用的中间体。